BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

  March 10, 2026

   · 

  16 min read
• Press Releases

  Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia

  March 10, 2026

   · 

  13 min read
• Press Releases

  Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results

  March 10, 2026

   · 

  11 min read
• Press Releases

  VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.

  March 10, 2026

   · 

  6 min read
• Press Releases

  Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.

  March 10, 2026

   · 

  5 min read
• Press Releases

  MBX Biosciences Appoints Karen Basbaum as Chief Business Officer

  March 10, 2026

   · 

  5 min read
• Press Releases

  Cerevance to Present Phase 2 Trial Results on OFF Time and Sleep‑Related Outcomes with Solengepras in Parkinson’s Disease at AD/PD™ 2026

  March 10, 2026

   · 

  4 min read
• Press Releases

  LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia

  March 10, 2026

   · 

  7 min read
• Press Releases

  ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

  March 10, 2026

   · 

  12 min read
• Press Releases

  Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau

  March 10, 2026

   · 

  7 min read